FI96864C - Ei-terapeuttisesti käytettävä HIV:n glykoproteiini GP 160 ja menetelmä sen valmistamiseksi - Google Patents

Ei-terapeuttisesti käytettävä HIV:n glykoproteiini GP 160 ja menetelmä sen valmistamiseksi

Info

Publication number
FI96864C
FI96864C FI885629A FI885629A FI96864C FI 96864 C FI96864 C FI 96864C FI 885629 A FI885629 A FI 885629A FI 885629 A FI885629 A FI 885629A FI 96864 C FI96864 C FI 96864C
Authority
FI
Finland
Prior art keywords
preparing
same
therapeutically useful
hiv glycoprotein
useful hiv
Prior art date
Application number
FI885629A
Other languages
English (en)
Swedish (sv)
Other versions
FI885629A0 (fi
FI885629L (fi
FI96864B (fi
Inventor
Johann Eibl
Friedrich Dorner
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of FI885629A0 publication Critical patent/FI885629A0/fi
Publication of FI885629L publication Critical patent/FI885629L/fi
Application granted granted Critical
Publication of FI96864B publication Critical patent/FI96864B/fi
Publication of FI96864C publication Critical patent/FI96864C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
FI885629A 1987-12-23 1988-12-02 Ei-terapeuttisesti käytettävä HIV:n glykoproteiini GP 160 ja menetelmä sen valmistamiseksi FI96864C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP87119172A EP0321606B1 (de) 1987-12-23 1987-12-23 Zelluläre amphipatische Proteine in aggregierten Formen und Verfahren zur Herstellung und Reinigung diese Proteine
EP87119172 1987-12-23

Publications (4)

Publication Number Publication Date
FI885629A0 FI885629A0 (fi) 1988-12-02
FI885629L FI885629L (fi) 1989-06-24
FI96864B FI96864B (fi) 1996-05-31
FI96864C true FI96864C (fi) 1996-09-10

Family

ID=8197541

Family Applications (2)

Application Number Title Priority Date Filing Date
FI885629A FI96864C (fi) 1987-12-23 1988-12-02 Ei-terapeuttisesti käytettävä HIV:n glykoproteiini GP 160 ja menetelmä sen valmistamiseksi
FI953141A FI97058C (fi) 1987-12-23 1995-06-22 Menetelmä soluissa tuotettavan HIV:n glykoproteiinin GP 160 eristämiseksi ja puhdistamiseksi

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI953141A FI97058C (fi) 1987-12-23 1995-06-22 Menetelmä soluissa tuotettavan HIV:n glykoproteiinin GP 160 eristämiseksi ja puhdistamiseksi

Country Status (8)

Country Link
EP (1) EP0321606B1 (fi)
JP (1) JP2656098B2 (fi)
AT (1) ATE95188T1 (fi)
DE (1) DE3787654D1 (fi)
DK (1) DK628188A (fi)
ES (1) ES2059355T3 (fi)
FI (2) FI96864C (fi)
NO (1) NO175782C (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672895B1 (fr) * 1991-02-15 1995-05-12 Transgene Sa Procede de purification d'une proteine fortement glycosylee.
FR2692898B1 (fr) * 1992-06-30 1995-06-02 Centre Nat Rech Scient Procédé d'obtention de protéines membranaires, et utilisation de ces protéines dans un but de diagnostic ou de vaccination.
US5914390A (en) * 1997-05-12 1999-06-22 Celtrix Pharmaceuticals, Inc. Methods for increasing yields of recombinant proteins
DE19939246A1 (de) 1999-08-19 2001-02-22 Phasys Gmbh M Rückfaltung von Membranproteinen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61233700A (ja) * 1984-12-24 1986-10-17 ジエネンテク，インコ−ポレイテツド 分子クロ−ンされたエイズ関連ポリペプチド
CN86100979A (zh) * 1985-02-07 1986-12-17 史密丝克莱恩贝克曼公司 疟疾疫苗的制备方法
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
JPS62198627A (ja) * 1986-02-26 1987-09-02 Biseibutsu Kagaku Kenkyusho:Kk オ−エスキ−病可溶化抗原ワクチン

Also Published As

Publication number Publication date
FI953141A0 (fi) 1995-06-22
ES2059355T3 (es) 1994-11-16
FI953141L (fi) 1995-06-22
FI97058C (fi) 1996-10-10
NO885738L (no) 1989-06-26
NO885738D0 (no) 1988-12-23
ATE95188T1 (de) 1993-10-15
EP0321606B1 (de) 1993-09-29
JP2656098B2 (ja) 1997-09-24
DK628188D0 (da) 1988-11-10
NO175782B (no) 1994-08-29
FI885629A0 (fi) 1988-12-02
NO175782C (no) 1994-12-07
JPH02798A (ja) 1990-01-05
FI885629L (fi) 1989-06-24
EP0321606A1 (de) 1989-06-28
FI97058B (fi) 1996-06-28
FI96864B (fi) 1996-05-31
DE3787654D1 (de) 1993-11-04
DK628188A (da) 1989-06-24

Similar Documents

Publication Publication Date Title
DE69031791D1 (de) Verfahren zur HCV-Züchtung in Zell-Linien aus B- oder T-Lymphozyten
IT1177783B (it) Materiali amorfi resistenti all'usura ed articoli prodotti con essi,nonche' procedimento per la loro fabbricazione
IT1214189B (it) Vino a basso tenore alcolico. procedimento per la produzione di
BG42185A3 (en) Method for preparing pyridylic compounds
IT1211545B (it) Procedimento e impianto per la denaturazione di vernici
BG39976A3 (en) Method for preparing benzamides
FI96864C (fi) Ei-terapeuttisesti käytettävä HIV:n glykoproteiini GP 160 ja menetelmä sen valmistamiseksi
IT1231827B (it) Impianto per allineare pezze tessili allo scopo di tagliarle a fili diritti.
BG38781A3 (en) Aqueous perticide concentrate
IT1184993B (it) Carro pianale per sostituire o posare rispettivamente smontare,nonche' per trasportare telai di binari
ATE133709T1 (de) Peroxidase-gen von mikrobischem ursprung
BR8703701A (pt) Montagem de prensa
IT8720717A0 (it) Macchina spruzzatrice principalmente per la dispersione di soluzione di spruzzatura proporzionatamente all'area.
FI874808L (fi) Process foer koncentrering av en karbamidloesning och apparatur foer genomfoerande av processen.
IT8720436A0 (it) Processo per la preparazione del 2,4-diammino-6-(1-piperidinil)-piri mi-din-n-ossido.
FR2554812B1 (fr) Procede de preparation de 1,3-bis(3-aminophenoxy) benzene
FI911282L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 3,4-dihydroksi-2,5-dihydrofuranonien valmistamiseksi
DE69014644D1 (de) Somatische embryogenese von kürbissen.
FR2661845B1 (fr) Procede d'enrichissement de l'andalousite par flottation.
FI884488L (fi) En laogviskoes, vattenfri suspension innehaollande organofil lera och ett fyllnadsmedel med laog taethet.
Casper Collection quotas and the conservation of Mediterranean tortoises.
FR2558177B1 (fr) Machine d'effilochage pour convertir par effilochage des fibres chimiques
IT8323989A0 (it) Processo per la produzione dichetoni alifatici superiori in stadio singolo.
Tarasevich et al. Polyborates as modifying agents for nonsintering ceramic bodies
BG37076A3 (en) Method for preparing 5, 6- dihydro- 2- methyl- n- phenyl- 1, 4- oxatyine- 3- carboxamide

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: IMMUNO AKTIENGESELLSCHAFT